GlaxoSmithKline (GSK) has achieved a significant breakthrough in its efforts to ...
GlaxoSmithKline (GSK) has jolted the pharmaceutical community with its abrupt de...
AstraZeneca has secured a significant deal in the competitive field of cancer re...
In response to the escalating demand for its GLP-1 weight loss products, Novo No...
Merck & Co. has openly expressed its continuous pursuit of acquisitions, and cur...
In a recent legal skirmish in the biotechnology sector, NanoString finds itself ...
The Swedish biotech InDex has delivered surprising news to investors, announcing...
Novo Nordisk has announced a substantial investment of €2.1 billion to expand it...
Eli Lilly, a U.S.-based pharmaceutical company, has announced plans to construct...
In a significant setback for Germany’s pharmaceutical giant Bayer, the company h...
The Phase 1b unrestricted-label, eight-week residential trial meant to assess t...
Merck & Co. is racing against the clock to launch the first medication for chron...
Gilead Sciences subsidiary, Kite Pharma, is allocating $285 million towards adva...
Teva has tapped into royalty funding to speed up the development of an antipsych...
Researchers at New York University have made an important discovery in the field...
Earlier this month, Pfizer, the pharmaceutical giant, extended its cost-cutting ...
